Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer

NCT02520063 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Letrozole
DRUG: Everolimus
DRUG: TRC105

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]